Bee venom in cancer therapy

Cancer and Metastasis Reviews

Volumn 31, Issue 1-2, 2012, Pages 173-194

  Oršolić, Nada ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Bee venom; Cancer cells; Melittin; Phospholipase A2; Tumors

Indexed keywords

4 AMINOBUTYRIC ACID; ACID PHOSPHATASE; ALPHA AMINO ACID; ALPHA GLUCOSIDASE; ANTINEOPLASTIC AGENT; APAMIN; BEE VENOM; BLEOMYCIN; CALMODULIN; CALPAIN; CECROPIN; CIMETIDINE; DOPAMINE; DOXORUBICIN; FRUCTOSE; GELATINASE B; GLUCOSE; HISTAMINE; HYALURONIDASE; LYSOPHOSPHOLIPASE; MELITTIN; NORADRENALIN; PHOSPHATASE; PHOSPHOLIPASE A2; PROTEINASE INHIBITOR; RAC1 PROTEIN; SCOPOLAMINE METHYL BROMIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNINDEXED DRUG; VINCRISTINE;

ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ASTROCYTOMA CELL; BIOLOGICAL ACTIVITY; BREAST CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER INVASION; CANCER PATIENT; CANCER SURVIVAL; CANCER THERAPY; CELL ASSAY; CELL DEATH; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL TRIAL (TOPIC); CYTOTOXICITY; DNA SYNTHESIS INHIBITION; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MEGADOSE; DRUG TARGETING; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; IC 50; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; LEWIS CARCINOMA; LIVER CELL CARCINOMA; LUNG CANCER; LUNG METASTASIS; MELANOMA CELL; METASTASIS; MULTIPLE SCLEROSIS; NEOVASCULARIZATION (PATHOLOGY); NEUROTOXICITY; NONHUMAN; OSTEOSARCOMA CELL; OVARY CARCINOMA; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BEE VENOMS; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84862337185     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-011-9339-3     Document Type: Review

References (183)

1. Habermann, E. (1972). Bee and wasp venoms. The biochemistry and pharmacology of their peptides and enzymes are reviewed. Science, 177, 314-322.
2. Raghuraman, H., & Chattopadhyay, A. (2007). Melittin: a membrane-active peptide with diverse functions. Bioscience Reports, 27(4-5), 189S-223S.
3. Kwon, Y. B., Lee, J. D., Lee, H. J., Han, H. J., Mar, W. C., Kang, S. K., Beitz, A. J., & Lee, J. H. (2001). Bee venom injection into an acupuncture point reduces arthritis associated edema and nociceptive responses. Pain, 90, 271-280. (Pubitemid 32162949)
4. Park, H. J., Lee, S. H., Son, D. J., Oh, K. W., Kim, K. H., Song, H. S., Kim, G. J., Oh, G. T., Yoon, D. Y., & Hong, J. T. (2004). Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit. Arthritis and Rheumatism, 50 (11), 3504-3515.
5. Liu, X., Chen, D., Xie, L., & Zhang, R. (2002). Effect of honey bee venom on proliferation of K1735M2 mouse melanoma cells in-vitro and growth of murine B16 melanomas in-vivo. Journal of Pharmacy and Pharmacology, 54(8), 1083-1089.
6. Oršolić, N., Knežević, A., Šver, L., Terzić, S., Hackenberger, B. K., & Bašić, I. (2003). Influence of honey bee products on transplantable murine tumors. Veterinary and Comparative Oncology, 1(4), 216-226.
7. Oršolić, N., Šver, L., Verstovšek, S., Terzić, S., & Bašić, I. (2003). Inhibition of mammary carcinoma cell proliferation in vitro and tumor growth in vivo by bee venom. Toxicon, 41(7), 861-870.
8. Russell, P. J., Hewish, D., Carter, T., Sterling-Levis, K., Ow, K., Hattarki, M., Doughty, L., Guthrie, R., Shapira, D., Molloy, P. L., Werkmeister, J. A., & Kortt, A. A. (2004). Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies. Cancer Immunology, Immunotherapy, 53(5), 411-421. (Pubitemid 38657254)
9. Moon, D. O., Park, S. Y., Heo, M. S., Kim, K. C., Park, C., &Ko, W. S. (2006). Key regulators in bee venom-induced apoptosis are Bcl-2 and caspase-3 in human leukemic U937 cells through downregulation of ERK and Akt. International Immunopharmacology, 6(12), 1796-1807. (Pubitemid 44557188)
10. Varanda, E. A., & Tavares, D. C. (1998). Radioprotection: mechanism and radioprotective agents including honey bee venom. Venom Anim Toxins, 4(1), 5-21. (Pubitemid 28046054)
11. Varanda, E. A., Monti, R., & Tavares, D. C. (1999). Inhibitory effect of propolis and bee venom on the mutagenicity of some direct- and indirect-acting mutagens. Teratogenesis Carcinogenesis and Mutagenesis, 19(6), 403-413.
12. Nam, K. W., Je, K. H., Lee, J. H., Han, H. J., Lee, H. J., Kang, S. K., & Mar, W. (2003). Inhibition of COX-2 activity and proinflammatory cytokines (TNF-alpha and IL-1beta) production by water-soluble sub-fractionated parts from bee (Apis mellifera) venom. Archives of Pharmacal Research, 26(5), 383-388.
13. Kim, H. W., Kwon, Y. B., Ham, T. W., Roh, D. H., Yoon, S. Y., Lee, H. J., Han, H. J., Yang, I. S., Beitz, A. J., & Lee, J. H. (2003). Acupoint stimulation using bee venom attenuates formalin-induced pain behavior and spinal cord fos expression in rats. Journal of Veterinary and Medicine Science, 65(3), 349-355. (Pubitemid 41380152)
14. Son, D. J., Lee, J. W., Lee, Y. H., Song, H. S., Lee, C. K., &Hong, J. T. (2007). Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacology & Therapeutics, 115(2), 246-270. (Pubitemid 47053894)
15. Jang, M. H., Shin, M. C., Lim, S., Han, S. M., Park, H. J., &Shin, I. (2003). Bee venom induces apoptosis and inhibits expression of cyclooxygenase-2 mRNA in human lung cancer cell line NCI-H1299. Jounal of Pharmacology Science, 91(2), 95-104. (Pubitemid 36575560)
16. Yin, C. S., Lee, H. J., Hong, S. J., Chung, J. H., & Koh, H. G. (2005). Microarray analysis of gene expression in chondrosarcoma cells treated with bee venom. Toxicon, 45(1), 81-91. (Pubitemid 39586571)
17. Hu, H., Chen, D., Li, Y., & Zhang, X. (2006). Effect of polypeptides in bee venom on growth inhibition and apoptosis induction of the human hepatoma cell line SMMC-7721 in-vitro and Balb/c nude mice in-vivo. Journal of Pharmacy and Pharmacology, 58(1), 83-89. (Pubitemid 43041999)
18. Han, S., Lee, K., Yeo, J., Kweon, H., Woo, S., Lee, M., Baek, H., Kim, S., & Park, K. (2007). Effect of honey bee venom on microglial cells nitric oxide and tumor necrosis factor-alpha production stimulated by LPS. Journal of Ethnopharmacology, 111(1), 176-181. (Pubitemid 46482892)
19. Hong, S. J., Rim, G. S., Yang, H. I., Yin, C. S., Koh, H. G., Jang, M. H., Kim, C. J., Choe, B. K., & Chung, J. H. (2005). Bee venom induces apoptosis through caspase-3 activation in synovial fibroblasts of patients with rheumatoid arthritis. Toxicon, 46, 39-45.
20. Yusuf, N., Irby, C., Katiyar, S. K., & Elmets, C. A. (2007). Photoprotective effects of green tea polyphenols. Photodermatology, Photoimmunology and Photomedicine, 23, 48-56. (Pubitemid 46189311)
21. Leuschner, C., & Hansel, W. (2004). Membrane disrupting lytic peptides for cancer treatments. Current Pharmaceutical Desing, 10, 2299-2310. (Pubitemid 38855038)
22. Ling, C. Q., Li, B., Zhang, C., Gu, W., Li, S. X., Huang, X. Q., & Zhang, Y. N. (2004). Anti-hepatocarcinoma effect of recombinant adenovirus carrying melittin gene. Zhonghua Gan Zang Bing Za Zhi, 12(12), 741-744.
23. Eisenberg, D. (1984). Three-dimensional structure of membrane and surface proteins. Annual Review of Biochemistry, 53, 595-623.
24. Wade, D., Boman, A., Wahlin, B., Drain, C. M., Andreu, D., Boman, H. G., & Merrifield, R. B. (1990). The Proceedings of the National Academy of Sciences USA, 87, 4761-4765.
25. Katsu, T., Kuroko, M., Morikawa, T., Sanchika, K., Fujita, Y., Yamamura, H., & Uda, M. (1989). Mechanism of membrane damage induced by the amphipathic peptides gramicidin S and melittin. Biochimica et Biophysica Acta, 983, 135-141. (Pubitemid 19195264)
26. Dempsey, C. E. (1990). The actions of melittin on membranes. Biochimica et Biophysica Acta, 1031, 143-161.
27. Ladokhin, A. S., Selsted, M. E., & White, S. H. (1997). Sizing membrane pores in lipid vesicles by leakage of co-encapsulated markers: pore formation by melittin. Biophysical Journal, 72, 1762-1766. (Pubitemid 27133115)
28. Kiesel, L., Rabe, T., Hauser, G., Przylipiak, A., Jadali, F., &Runnebaum, B. (1987). Stimulation of luteinizing hormone release by melittin and phospholipase A2 in rat pituitary cells. Molecular and Cellular Endocrinology, 51, 1-6. (Pubitemid 17065373)
29. Hui, S. W., Stewart, C. M., & Cherry, R. J. (1990). Biochimica et Biophysica Acta, 1023, 335-340.
30. Carrasquer, G., Li, M., Yang, S., & Schwartz, M. (1998). Effect of melittin on PD, resistance and short-circuit current in the frog gastric mucosa. Biochimica et Biophysica Acta, 1369, 346-354.
31. Mahady, G. B., Liu, C., & Beecher, C. W. (1998). Involvement of protein kinase and G proteins in the signal transduction of benzophenanthridine alkaloid biosynthesis. Phytochemistry, 48, 93-102.
32. Mau, S. E., & Vilhardt, H. (1997). Cross talk between substance P and melittin-activated cellular signaling pathways in rat lactotroph-enriched cell cultures. Journal of Neurochemistry, 69, 762-772. (Pubitemid 27327980)
33. Knowles, B., & Farndale, R. W. (1988). Activation of insect cell adenylate cyclase by Bacillus thuringiensis delta-endotoxins and melittin. Toxicity is independent of cyclic AMP. Biochemistry Journal, 253, 235-241.
34. Haber, M. T., Fukui, T., Lebowitz, M. S., & Lowenstein, J. M. (1991). Activation of phosphoinositide-specific phospholipase C delta from rat liver by polyamines and basic proteins. Archives of Biochemistra and Biophysics, 288, 243-249.
35. Haase, I., Czarnetzki, B. M., & Rosenbach, T. (1996). Thrombin and melittin activate phospholipase C in human HaCaT keratinocytes. Experimental Dermatology, 5, 84-88. (Pubitemid 26173964)
36. Lee, S. Y., Yeo, E., & Choi, M.-U. (1998). Phospholipase D activity in L1210 cells: a model for oleate-activated phospholipase D in intact mammalian cells. Biochemistry and Biophysics Reserch Communication, 244, 825-831. (Pubitemid 28418154)
37. Liu, S.-Y., Tappia, P. S., Dai, J., Williams, S. A., & Panagia, V. (1998). Phospholipase A2-mediated activation of phospholipase D in rat heart sarcolemma. Journal of Molecular and Cellular Cardiology, 30, 1203-1214. (Pubitemid 28327788)
38. Saini, S. S., Chopra, A. K., & Peterson, J. W. (1999). Melittin activates endogenous phospholipase D during cytolysis of human monocytic leukemia cells. Toxicon, 37, 1605-1619. (Pubitemid 29341494)
39. Fukushima, N., Kohno, M., Kato, T., Kawamoto, S., Okuda, K., Misu, Y., & Ueda, H. (1998). Melittin, a metabostatic peptide inhibiting Gs activity. Peptides, 19(5), 811-819. (Pubitemid 28312277)
40. Dennis, E. A. (1994). Diversity of group types, regulation, and function of phospholipase A2. Journal of Biological Chemistry, 269, 13057-13060.
41. Six, D. A., & Dennis, E. A. (2000). The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochimica et Biophysica Acta, 1488, 1-19.
42. Valentin, E., & Lambeau, G. (2000). What can venom phospholipases A(2) tell us about the functional diversity of mammalian secreted phospholipases A(2)? Biochimie, 82, 815-831.
43. Kudo, I., & Murakami, M. (2002). Phospholipase A2 enzymes. Prostaglandins & Other Lipid Mediators, 68-69, 3-58.
44. Lambeau, G., Schmid-Alliana, A., Lazdunski, M., & Barhanin, J. (1990). Identification and purification of a very high affinity binding protein for toxic phospholipases A2 in skeletal muscle. Journal of Biology and Chemistry, 265, 9526-9532.
45. Lambeau, G., & Lazdunski, M. (1999). Receptors for a growing family of secreted phospholipases A2. Trends in Pharmacology Science, 20, 162-170.
46. Fonteh, A. N., Atsumi, G., LaPorte, T., & Chiltonm, F. H. (2000). Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells. Journal of Immunology, 165, 2773-2782. (Pubitemid 30660728)
47. Graler, M. H., & Goetzl, E. J. (2002). Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochimica et Biophysica Acta, 1582, 168-174. (Pubitemid 34634126)
48. Kabarowski, J. H., Xu, Y., & Witte, O. N. (2002). Lysophosphatidyl choline as a ligand for immunoregulation. Biochemistry and Pharmacology, 64, 161-167.
49. Andresen, T. L., Jensen, S. S., Madsen, R., & Jorgensen, K. (2005). Synthesis and biological activity of anticancer ether lipids that are specifically released by phospholipase A2 in tumor tissue. Journal of Medicinal Chemistry, 48, 7305-7314. (Pubitemid 41743644)
50. Ruiter, G. A., Verheij, M., Zerp, S. F., & van Blitterswijk, W. J. (2001). Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis. International Journal of Radiation Oncology, Biology, Physics, 49, 415-419. (Pubitemid 32120238)
51. Ruiter, G. A., Zerp, S. F., Bartelink, H., van Blitterswijk, W. J., & Verheij, M. (2003). Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway. Anti-Cancer Drugs, 14, 167-173. (Pubitemid 36269756)
52. Samadder, P., Bittman, R., Byun, H. S., & Arthur, G. (2004). Synthesis and use of novel ether phospholipid enantiomers to probe the molecular basis of the antitumor effects of alkyllysophospholipids: correlation of diferential activation of c-Jun NH (2)-terminal protein kinase with antiproliferative effects in neuronal tumor cells. Journal of Medicinal Chemistry, 47, 2710-2713. (Pubitemid 38580109)
53. Winder, D., Günzburg, W. H., Erfle, V., & Salmons, B. (1998). Expression of antimicrobial peptides has an antitumour effect in human cells. Biochemical and Biophysical Resech Commununication, 242(3), 608-612. (Pubitemid 28412575)
54. Oršolić, N., Terzić, S., Šver, L., & Bašić, I. (2005). Honey-bee products in preventive and/or therapy of murine transplantable tumours. Journal of the Science of Food and Agriculture, 85, 363-370.
55. Duke, R. C., Witter, R. Z., Nash, P. B., Young, J. D., & Ojcius, D. M. (1994). Cytolysis mediated by ionophores and pore-forming agents: role of intracellular calcium in apoptosis. The FASEB Journal, 8, 237-246. (Pubitemid 24067148)
56. Li, B., Gu, W., Zhang, C., Huang, X. Q., Han, K. Q., & Ling, C. Q. (2006). Growth arrest and apoptosis of the human hepatocellular carcinoma cell line BEL-7402 induced by melittin. Onkologie, 29(8-9), 367-371. (Pubitemid 44370805)
57. Chu, S. T., Cheng, H. H., Huang, C. J., Chang, H. C., Chi, C. C., Su, H. H., Hsu, S. S., Wang, J. L., Chen, I. S., Liu, S. I., Lu, Y. C., Huang, J. K., Ho, C. M., & Jan, C. R. (2007). Phospholipase A2-independent Ca2+ entry and subsequent apoptosis induced by melittin in human MG63 osteosarcoma cells. Life Science, 80 (4), 364-369.
58. Zhang, C., Li, B., Lu, S. Q., Li, Y., Su, Y. H., & Ling, C. Q. (2007). Effects of melittin on expressions of mitochondria membrane protein 7A6, cell apoptosis-related gene products Fas and Fas ligand in hepatocarcinoma cells. Zhong Xi Yi Jie He Xue Bao, 5, 559-563. (Pubitemid 47455611)
59. Liu, S., Yu, M., He, Y., Xiao, L., Wang, F., Song, C., Sun, S., Ling, C., & Xu, Z. (2008). Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology, 47(6), 1964-1973. (Pubitemid 351945563)
60. Sharma, S. V. (1993). Melittin-induced hyperactivation of phospholipase A2 activity and calcium influx in ras-transformed cells. Oncogene, 8(4), 939-947.
61. Sharma, S. V. (1992). Melittin resistance: a counterselection for ras transformation. Oncogene, 7, 193-201.
62. Oršolić, N. (2009). Potentiation of Bleomycin lethality on HeLa and V79 cells by bee venom. Arhives of Industrial Hygiene and Toxicology, 60, 317-326.
63. Tsuro, T., Iida, H., Tsukagoshi, S., & Sakurai, Y. (1982). Increased accumulation of vineristine and adriamycin in drugresistant P388 tumor cells following with calcium antagonists and calmodulin inhibitors. Cancer Reserch, 42, 4730-4733. (Pubitemid 13205981)
64. Chafouleas, J. G., Botton, W. E., & Means, A. R. (1984). Potentiation of bleomycin lethality by anti-calmodulin drugs: a role for calmodulin in DNA repair. Science, 224, 1346-1348. (Pubitemid 14113629)
65. Lee, G. L., & Hait, W. N. (1985). Growth inhibition of C6 astrocytoma cells by inhibitions of calmodulin. Life Science, 36, 347-354. (Pubitemid 15193339)
66. Lazo, J. S., Hait, W. N., Kennedy, K. A., Braun, I. D., &Meandzija, B. (1985). Enhanced bleomycin-induced DNAdamage and cytotoxicity with calmodulin antagonists. Molecular Pharmacology, 27(3), 387-393. (Pubitemid 15142337)
67. Killion, J. J., & Dunn, J. D. (1986). Differential cytolysis of murine spleen, bone-marrow and leukemia cells by melittin reveals differences in membrane topography. Biochemical and Biophysical Research Communication, 139, 222-227. (Pubitemid 16007266)
68. Chueng, W. Y. (1982). Calmodulin: an overview. Federation Proceedings, 41(7), 2253-2257.
69. Gerst, J. E., & Salomon, Y. (1987). Inhibition by melittin and fluphenazine of melanotropin receptor function and adenylate cyclase in M2R melanoma cell membranes. Endocrinology, 121 (5), 1766-1772. (Pubitemid 18012782)
70. Vento, R., D'Alessandro, N., Giuliano, M., Lauricella, M., Carabillò, M., & Tesoriere, G. (2000). Induction of apoptosis by arachidonic acid in human retinoblastoma Y79 cells: involvement of oxidative stress. Experimental Eye Reserch, 70 (4), 503-517. (Pubitemid 30658892)
71. Arioka, M., Cheon, S. H., Ikeno, Y., Nakashima, S., & Kitamoto, K. (2005). A novel neurotrophic role of secretory phospholipases A2 for cerebellar granule neurons. FEBS Letters, 579(12), 2693-2701. (Pubitemid 40615679)
72. Shaposhnikova, V. V., Egorova, M. V., Kudryavtsev, A. A., Levitman, M. Kh., & Korystov, Yu. N. (1997). The effect of melittin on proliferation and death of thymocytes. FEBS Letters, 410(2-3), 285-288. (Pubitemid 27304080)
73. Oršolić, N., Šver, L., Bendelja, K., & Bašić, I. (2001). Antitumor activity of bee venom. Periodicum Biologorum, 103, 49-54.
74. Weston, K. M., & Raison, R. L. (1998). Interaction of melittin with a human lymphoblastoid cell line, HMy2. Journal Cell Biochemistry, 68(2), 164-173. (Pubitemid 28028074)
75. Tosteson, M. T., & Tosteson, D. C. (1981). The sting: melittin forms channels in lipid bilayers. Biophysics Journal, 36, 109-116. (Pubitemid 12216808)
76. Vogel, H., & Jähnig, F. (1986). The structure of melittin in membranes. Biophysical Journal, 50(4), 573-582.
77. Laine, R. O., Morgan, B. P., & Esser, A. F. (1988). Comparison between complement and melittin hemolysis: anti-melittin antibodies inhibit complement lysis. Biochemistry, 27(14), 5308-5314.
78. Pawlak Pawlak, M., Meseth, U., Dhanapal, B., Mutter, M., &Vogel, H. (1994). Template-assembled melittin: structural and functional characterization of a designed, synthetic channel-forming protein. Protein Science, 3(10), 1788-1805. (Pubitemid 24356603)
79. Benachir, T., & Lafleur, M. (1995). Study of vesicle leakage induced by melittin. Biochimica et Biophysica Acta, 1235(2), 452-460.
80. DeGrado, W. F., Musso, G. F., Lieber, M., Kaiser, E. T., &Kézdy, F. J. (1982). Kinetics and mechanism of hemolysis induced by melittin and by a synthetic melittin analogue. Biophysical Journal, 37(1), 329-338. (Pubitemid 12150026)
81. Matsuzaki, K., Yoneyama, S., & Miyajima, K. (1997). Pore formation and translocation of melittin. Biophysical Journal, 73 (2), 831-838. (Pubitemid 27337617)
82. Shier, W. T. (1979). Activation of high levels of endogenous phospholipase A2 in cultured cells. The Proceedings of the National Academy of Sciences USA, 76(1), 195-199.
83. Fletcher, J. E., & Jiang, M. S. (1993). Possible mechanisms of action of cobra snake venom cardiotoxins and bee venom melittin. Toxicon, 31(6), 669-695.
84. Sarin, A., Adams, D. H., & Henkart, P. A. (1993). Protease inhibitors selectively block T cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T cells. The Journal of Experimental Medicine, 178(5), 1693-1700. (Pubitemid 23318448)
85. Squìer, M. K., Miller, A. C., Malkinson, A. M., & Cohen, J. J. (1994). Calpain activation in apoptosis. Journal of Cell Physiology, 159(2), 229-237. (Pubitemid 24141929)
86. Goodman, S. R., Krebs, K. E., Whitfield, C. F., Riederer, B. M., & Zagon, I. S. (1988). Spectrin and related molecules. CRC Critical Reviews in Biochemistry, 23(2), 171-234.
87. 2+-dependent protease during platelet activation. Blood, 69, 537-545.
88. Harris, A. S., Croall, D. E., & Morrow, J. S. (1988). The calmodulin-binding site in alpha-fodrin is near the calcium-dependent protease-I cleavage site. Journal of Biological Chemistry, 263, 15754-15761.
89. Harris, A. S., & Morrow, J. S. (1990). Calmodulin and calcium-dependent protease I coordinately regulate the interaction of fodrin with actin. The Proceedings of the National Academy of Sciences USA, 87, 3009-3013.
90. Arora, A.S., deGroen, P., Emori,Y., Gores,G.J. (1996)A cascade of degradative hydrolase activity contributes to hepatocyte necrosis during anoxia. The American Journal of Physiology, 270(2 Pt1), G238-G245.
91. Wu, Y. L., Jiang, X. R., Newland, A. C., & Kelsey, S. M. (1998). Failure to activate cytosolic phospholipase A2 causes TNF resistance in human leukemic cells. Journal of Immunology, 160 (12), 5929-5935. (Pubitemid 28298053)
92. Midoux, P., Mayer, R., & Monsigny, M. (1995). Membrane permeabilization by alpha-helical peptides: a flow cytometry study. Biochimica et Biophysica Acta, 1239, 249-256. (Pubitemid 3001236)
93. Clapp, L. E., Klette, K. L., DeCoster, M. A., Bernton, E., Petras, J. M., Dave, J. R., Laskosky, M. S., Smallridge, R. C., &Tortella, F. C. (1995). Phospholipase A2-induced neurotoxicity in vitro and in vivo in rats. Brain Reserch, 693, 101-111.
94. Lee, S. Y., Park, H. S., Lee, S. J., & Choi, M. U. (2001). Melittin exerts multiple effects on the release of free fatty acids from L1210 cells: lack of selective activation of phospholipase A2 by melittin. Archives of Biochemistry and Biophysics, 389(1), 57-67.
95. Mihajlovic, M., & Lazaridis, T. (2010). Antimicrobial peptides in toroidal and cylindrical pores. Biochimica et Biophysica Acta, 1798(8), 1485-1493.
96. Putz, T., Ramoner, R., Gander, H., Rahm, A., Bartsch, G., &Thurnher, M. (2006). Antitumor action and immune activation through cooperation of bee venom secretory phospholipase A2 and phosphatidylinositol-(3,4)-bisphosphate. Cancer Immunology, Immunotherapy, 55(11), 1374-1383. (Pubitemid 44187669)
97. Engers, R., & Gabbert, H. E. (2000). Mechanisms of tumor metastasis: cell biological aspects and clinical implications. Journal of Cancer Reserch and Clinical Oncology, 126, 682-692.
98. Lester, B. R., & McCarthy, J. B. (1992). Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion and metastasis. Cancer Metastasis Review, 11, 31-44.
99. Cho, H. J., Jeong, Y. J., Park, K. K., Park, Y. Y., Chung, I. K., Lee, K. G., Yeo, J. H., Han, S. M., Bae, Y. S., & Chang, Y. C. (2010). Bee venom suppresses PMA-mediated MMP-9 gene activation via JNK/p38 and NF-kappaB-dependent mechanisms. Journal of Ethnopharmacology, 127(3), 662-668.
100. Park, J. H., Jeong, Y. J., Park, K. K., Cho, H. J., Chung, I. K., Min, K. S., Kim, M., Lee, K. G., Yeo, J. H., Park, K. K., &Chang, Y. C. (2010). Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-kappaB and AP-1-dependent MMP-9 expression. Molecular Cells, 29(2), 209-215.
101. Zetter, B. R. (1990). The cellular basis of site-specific tumor metastasis. The New England Journal of Medicine, 322, 605-612.
102. Tang, D. G., & Honn, K. V. (1994). Adhesion molecules and tumor metastasis: an update. Invasion & Metastasis, 14, 109-122.
103. Kannagi, R. (1997). Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconjugate Journal, 14, 577-584.
104. Oršolić, N., & Bašić, I. (2003). Apoptosis and necrosis as possible mechanisms for antitumor activity of bee venom. Mellifera, 3, 34-42.
105. Ćurić, S., Oršolić, N., Krsnik, B., Balenović, T., Valpotić, I., Sulimanović, Crossed D sign., & Bašić, I. (1993). Immune responses of a mouse to bee venom. Stočarstvo, 47, 131-136.
106. Huh, J. E., Baek, Y. H., Lee, M. H., Choi, D. Y., Park, D. S., &Lee, J. D. (2010). Bee venom inhibits tumor angiogenesis and metastasis by inhibiting tyrosine phosphorylation of VEGFR-2 in LLC-tumor-bearing mice. Cancer Letters, 292(1), 98-110.
107. Ling, C. Q., Li, B., Zhang, C., Zhu, D. Z., Huang, X. Q., Gu, W., & Li, S. X. (2005). Inhibitory effect of recombinant adenovirus carrying melittin gene on hepatocellular carcinoma. Annals of Oncology, 16(1), 109-115. (Pubitemid 40124487)
108. Hansel, W., Enright, F., & Leuschner, C. (2007). Destruction of breast cancers and their metastases by lytic peptide conjugates in vitro and in vivo. Molecular and Cellular Endocrinology, 260-262, 183-189. (Pubitemid 44792362)
109. Hansel,W., Leuschner, C.,& Enright, F. (2007). Conjugates of lytic peptides and LHRH or betaCG target and cause necrosis of prostate cancers and metastases. Molecular and Cellular Endocrinology, 269, 26-33. (Pubitemid 46483829)
110. Kumar, C. S., Leuschner, C., Doomes, E. E., Henry, L., Juban, M., & Hormes, J. (2004). Efficacy of lytic peptide bound magnetite nanoparticles in destroying breast cancer cells. Journal of Nanoscience and Nanotechnology, 4, 245-249. (Pubitemid 38824426)
111. Jaynes, J. M., Julian, G. R., Jeffers, G. W., White, K. L., &Enright, F. M. (1989). Peptide Research, 2, 157-160.
112. Moore, A. J., Devine, D. A., Bibby, M. C., Moore, A. J., Beazley, W. D., Bibby, M. C., & Devine, D. A. (1996). Antimicrobial activity of cecropins. Journal of Antimicrobial Chemotherapy, 37(6), 1077-1089. (Pubitemid 26258054)
113. Werkmeister, J. A., Kirkpatrick, A., McKenzie, J. A., & Rivett, D. E. (1993). The effect of sequence variations and structure on the cytolytic activity of melittin peptides. Biochimica et Biophysica Acta, 1157, 50-54. (Pubitemid 23138469)
114. Ferguson, E. L., & Duncan, R. (2009). Dextrin-phospholipase A2: synthesis and evaluation as a bioresponsive anticancer conjugate. Biomacromolecules, 10(6), 1358-1364.
115. Barrajón-Catalán, E., Menéndez-Gutiérrez, M. P., Falco, A., Carrato, A., Saceda, M., & Micol, V. (2010). Selective death of human breast cancer cells by lytic immunoliposomes: correlation with their HER2 expression level. Cancer Letters, 290(2), 192-203.
116. Baban, D. F., & Seymour, L. W. (1998). Control of tumor vascular permeability. Advanced Drug Delivery Reviews, 34, 109-119.
117. Shubik, P. (1982). Vascularization of tumors: a review. Journal of Cancer Reserch and Clinical Oncology, 103, 211-226.
118. Rubin, P., & Casarett, G. (1966). Microcirculation of tumors. I. Anatomy, function, and necrosis. Clinical Radiology, 17, 220-229.
119. Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998). Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. The Proceedings of the National Academy of Sciences USA, 95, 4607-4612. (Pubitemid 28207960)
120. Soman, N. R., Baldwin, S. L., Hu, G., Marsh, J. N., Lanza, G. M., Heuser, J. E., Arbeit, J. M., & Wickline, S. A. (2009). Schlesinger PH. Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth. Journal of Clincal Investigation, 119(9), 2830-2842.
121. Holle, L., Song, W., Holle, E., Wei, Y., Li, J., Wagner, T. E., &Yu, X. (2009). In vitro- and in vivo-targeted tumor lysis by an MMP2 cleavable melittin-LAP fusion protein. International Journal of Oncology, 35(4), 829-835.
122. Gawronska, B., Leuschner, C., Enright, F. M., & Hansel, W. (2002). Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo. Gynecologic Oncology, 85(1), 45-52. (Pubitemid 34304009)
123. Leuschner, C., Enright, F. M., Melrose, P. A., & Hansel, W. (2001). Targeted destruction of androgen-sensitive and - insensitive prostate cancer cells and xenografts through luteinizing hormone receptors. Prostate, 46, 116-126.
124. Hansel, W., Leuschner, C., Gawronska, B., & Enright, F. M. (2001). Targeted destruction of prostate cancer cells and xenografts by lytic peptide-LH. Reproductive Biology, 1, 20-32.
125. Sancar, A., Lindsey-Boltz, L. A., Unsal-Kacmaz, K., & Linn, S. (2004). Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annual Review of Biochemistry, 73, 39-85. (Pubitemid 39050363)
126. Hait, W. N., Cadman, E., Benz, C., Cole, J., & Weiss, B. (1983). Inhibition of cyclic nucleotide phosphodiesterase and calmodulin. Proceedings of the American Association for Cancer Research, 2, 5-9.
127. Hait, W. N., Grais, L., Benz, C., & Cadman, E. C. (1985). Inhibition of growth of leukemic cells by inhibitors of calmodulin: phenothiazines and melittin. Cancer Chemotherapy and Pharmacology, 14, 202-205. (Pubitemid 15118638)
128. Hait, W. N., & Lee, G. L. (1985). Characteristics of the cytotoxic effects of the phenothiazine class of calmodulin antagonists. Biochemical Pharmacology, 34(22), 3973-3978. (Pubitemid 16193505)
129. Okumara, K., Kato, T., Ito, J., & Tanaka, R. (1982). Inhibition by calmodulin antagonists of glioblast DNA synthesis and morphological changes induced by glial maturation factor. Developmental Brain Reserch, 255, 661-665.
130. Means, A. R., Chafouleas, J. A., Lagace, L., Lai, E., & Stein, J. P. (1982). Multiple roles for calmodulin in the regulation of eukarryotic cell metabolism. In Gene regulation (pp. 307-326). New York: Academic.
131. Chafouleas, J. G., Bolton, W. E., Hidaka, H., Boyd, A. E., &Means, A. R. (1982). Calmodulin and the cell cycle: involvement in regulation of cell cycle progression. Cell, 28, 41-50. (Pubitemid 12223306)
132. Gamapathi, R., & Grabowski, D. (1983). Enhancement of sensitivity to adriamyc in resistant P388 leukemia by the calmodulin inhibitor, trifluoperazine. Cancer Reserch, 43, 3696-3699.
133. Rahmanzadeh, R., Rai, P., Celli, J. P., Rizvi, I., Baron-Lühr, B., Gerdes, J., & Hasan, T. (2010). Ki-67 as a molecular target for therapy in an in vitro three-dimensional model for ovarian cancer. Cancer Reserch, 70(22), 9234-9242.
134. Bullwinkel, J., Baron-Lühr, B., Lüdemann, A., Wohlenberg, C., Gerdes, J., & Scholzen, T. (2006). Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. Journal of Cell Physiology, 206(3), 624-635. (Pubitemid 43191037)
135. Yang, Z. L., Ke, Y. Q., Xu, R. X., & Peng, P. (2007). Melittin inhibits proliferation and induces apoptosis of malignant human glioma cells. Nan Fang Yi Ke Da Xue Xue Bao, 27(11), 1775-1777.
136. Balk, S. D., Polimeni, P. I., Hoon, B. S., Lestourgeon, D. N., &Mitchell, R. S. (1979). Proliferation of Rous sarcoma virus-infected, but not of normal chicken fibroblasts in a medium of reduced calcium and magnesium concentration. The Proceedings of the National Academy of Sciences USA, 76, 3913-3916. (Pubitemid 9246998)
137. Whitfield, J. F., Boynton, A. L., Macmanus, J. P., Sicorska, M., & Tsang, B. K. (1979). The regulation of cell proliferation by calcium and cyclic AMP. Molecular and Cellular Biochemistry, 27, 155-179.
138. Zhao, M., Brunk, U. T., & Eaton, J. W. (2001). Delayed oxidant-induced cell death involves activation of phospholipase A2. FEBS Letters, 509(3), 399-404.
139. Li, B., Li, L. Y., Luo, X., & Wang, X. (2001). Endonuclease G is an apoptotic DNase when released from mitochondria. Nature, 412, 95-99. (Pubitemid 32851517)
140. Miramar, M. D., Costantini, P., Ravagnan, L., Saraiva, L. M., Haouzi, D., Brothers, G., Penninger, J. M., Peleato, M. L., Kroemer, G., & Susin, S. A. (2001). NADH oxidase activity of mitochondrial apoptosis-inducing factor. Journal of Biological Chemistry, 276(19), 16391-16398.
141. Kroemer, G., & Martin, S. J. (2005). Caspase-independent cell death. Nature Medicine, 11(7), 725-730. (Pubitemid 41021204)
142. Ip, S. W., Liao, S. S., Lin, S. Y., Lin, J. P., Yang, J. S., Lin, M. L., Chen, G. W., Lu, H. F., Lin, M. W., Han, S. M., & Chung, J. G. (2008). The role of mitochondria in bee venom-induced apoptosis in human breast cancer MCF7 cells. Vivo, 22(2), 237-245.
143. Ip, SW., Wei, HC., Lin, JP., Kuo, HM., Liu, KC., Hsu, SC., Yang, JS., Mei-Dueyang, Chiu, TH., Han, SM., Chung, JG (2008a) Bee venom induced cell cycle arrest and apoptosis in human cervical epidermoid carcinoma Ca Ski cells. Anticancer Research, 28(2A), 833-842.
144. Moon, D. O., Park, S. Y., Choi, Y. H., Kim, N. D., Lee, C., & Kim, G. Y. (2008). Melittin induces Bcl-2 and caspase-3-dependent apoptosis through downregulation of Akt phosphorylation in human leukemic U937 cells. Toxicon, 51(1), 112-120.
145. Wang, C., Chen, T., Zhang, N., Yang, M., Li, B., Lu, X., Cao, X., & Ling, C. (2009). Melittin, a major component of Bee Venom, sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis by activating CaMKII-TAK1-JNK/p38 and inhibiting IKK-NFkappa B. Journal of Biological Chemistry, 284(6), 3804-3813.
146. Grisotto, L. S., Mendes, G. E., Castro, I., Baptista, M. A., Alves, V. A., Yu, L., & Burdmann, E. A. (2006). Mechanisms of bee venom-induced acute renal failure. Toxicon, 48(1), 44-54. (Pubitemid 44137265)
147. Putz, T., Ramoner, R., Gander, H., Rahm, A., Bartsch, G., Bernardo, K., Ramsay, S., & Thurnher, M. (2007). Bee venom secretory phospholipase A2 and phosphatidylinositol-homologues cooperatively disrupt membrane integrity, abrogate signal transduction and inhibit proliferation of renal cancer cells. Cancer Immunology, Immunotherapy, 56(5), 627-640. (Pubitemid 46348733)
148. Andreae, S., Buisson, S., & Triebel, F. (2003). MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223). Blood, 102, 2130-2137. (Pubitemid 37122390)
149. Appel, S., Rupf, A., Weck, M. M., Schoor, O., Brummendorf, T. H., Weinschenk, T., Grunebach, F., & Brossart, P. (2005). Effects of imatinib on monocyte-derived dendritic cells are mediated by inhibition of nuclear factor-kappaB and Akt signaling pathways. Clinical Cancer Reserch, 11, 1928-1940. (Pubitemid 40471859)
150. Del Prete, A., Vermi, W., Dander, E., Otero, K., Barberis, L., Luini, W., Bernasconi, S., Sironi, M., Santoro, A., Garlanda, C., Facchetti, F., Wymann, M. P., Vecchi, A., Hirsch, E., Mantovani, A., & Sozzani, S. (2004). Defective dendritic cell migration and activation of adaptive immunity in I3Kgamma-deficient mice. EMBO Journal, 23, 3505-3515. (Pubitemid 39265540)
151. Payrastre, B., Missy, K., Giuriato, S., Bodin, S., Plantavid, M., &Gratacap, M. (2001). Phosphoinositides: key players in cell signalling, in time and space. Cellular Signalling, 13, 377-387. (Pubitemid 32510988)
152. Toker, A. (2002). Phosphoinositides and signal transduction. Cellular and Molecular Life Science, 59, 761-779.
153. Gille, H., & Downward, J. (1999). Multiple ras effector pathways contribute to G(1) cell cycle progression. Journal of Biological Chemistry, 274, 22033-22040.
154. Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordan, J., Bellacosa, A., Tsichlis, P. N., & Hay, N. (1997). The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes &Development, 11, 701-713. (Pubitemid 27157159)
155. Park, J. H., Kim, K. H., Kim, S. J., Lee, W. R., Lee, K. G., &Park, K. K. (2010). Bee venom protects hepatocytes from tumor necrosis factor-alpha and actinomycin D.Archives. Pharmacological Reserch, 33(2), 215-223.
156. Wang, W., & El-Deiry, W. S. (2008). Restoration of p53 to limit tumor growth. Current Opinion in Oncology, 20(1), 90-96. (Pubitemid 350190987)
157. Wiman, K. G. (2010). Pharmacological reactivation of mutant p53: from protein structure to the cancer patient. Oncogene, 29 (30), 4245-4252.
158. Vousden, K. H., & Lane, D. P. (2007). p53 in health and disease. Nature Reviews Molecular Cell Biology, 8, 275-283. (Pubitemid 46474662)
159. Shangary, S., Qin, D., McEachern, D., Liu, M., Miller, R. S., Qiu, S., Nikolovska-Coleska, Z., Ding, K., Wang, G., Chen, J., Bernard, D., Zhang, J., Lu, Y., Gu, Q., Shah, R. B., Pienta, K. J., Ling, X., Kang, S., Guo, M., Sun, Y., Yang, D., & Wang, S. (2008). Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition. The Proceedings of the National Academy of Sciences USA, 105, 3933-3938. (Pubitemid 351723502)
160. Li, C., Pazgier, M., Liu, M., Lu, W. Y., & Lu, W. (2009). Apamin as a template for structure-based rational design of potent peptide activators of p53. Angewandte Chemie International Edition in English, 48(46), 8712-8715.
161. Stocker, M. (2004). Ca(2+)-activated K+ channels: molecular determinants and function of the SK family. Nature Reviews Neuroscience, 5, 758-770.
162. Bykov, V. J., Issaeva, N., Shilov, A., Hultcrantz, M., Pugacheva, E., Chumakov, P., Bergman, J., Wiman, K. G., & Selivanova, G. (2002). Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound. Nature Medicine, 8 (3), 282-288. (Pubitemid 34250107)
163. Tongyoo, A. (2010). Targeted therapy: novel agents against cancer. Journal of the Medical Association of Thailand, 93(Suppl 7), S311-S323. Review.
164. Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell, 144(5), 646-674. Review.
165. Song CC, Lu X, Cheng BB, DU J, Li B, Ling CQ. (2007) Effects of melittin on growth and angiogenesis of human hepatocellular carcinoma BEL-7402 cell xenografts in nude mice. Ai Zheng, 26 (12), 1315-1322.
166. Weng, C. J., Chau, C. F., Yen, G. C., Liao, J. W., Chen, D. H., &Chen, K. D. (2009). Inhibitory effects of ganoderma lucidum on tumorigenesis and metastasis of human hepatoma cells in cells and animal models. Journal of Agricultural and Food Chemistry, 57(11), 5049-5057.
167. Kato, Y., Yamashita, T., & Ishikawa, M. (2002). Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells. Oncology Reports, 9(3), 565-569.
168. Liotta, L. A., & Stetler-Stevenson, W. G. (1991). Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Research, 51(18 Suppl)), 5054s-5059s. Review.
169. Rahman, K. M., Sarkar, F. H., Banerjee, S., Wang, Z., Liao, D. J., Hong, X., & Sarkar, N. H. (2006). Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model. Molecular Cancer Therapeutics, 5(11), 2747-2756. (Pubitemid 44849001)
170. Nabeshima, K., Inoue, T., Shimao, Y., & Sameshima, T. (2002). Matrix metalloproteinases in tumor invasion: role for cell migration. Pathology International, 52(4), 255-264. Review. (Pubitemid 34587810)
171. Bhoopathi, P., Chetty, C., Kunigal, S., Vanamala, S. K., Rao, J. S., & Lakka, S. S. (2008). Blockade of tumor growth due tomatrix metalloproteinase-9 inhibition is mediated by sequential activation of beta1-integrin, ERK, and NF-kappaB. Journal of Biological Chemistry, 283(3), 1545-1552.
172. Hamedani, M., Mirshafiey, A., Vatanpour, H., Khorramizadeh, M., Saadat, F., Berahmeh, A., & Hadji-Ghasemi, F. (2005). In vitro assessment of bee venom effects on matrix metalloproteinase activity and interferon production. Iranian Journal of Allergy, Asthma, and Immunology, 4(1), 9-14.
173. Hamedani, M., Vatanpour, H., Saadat, F., Reza Khorramizaheh, M., & Mirshafiey, A. (2005). Bee venom, immunostimulant or immunosuppressor? Insight into the effect on matrix metalloproteinases and interferons. Immunopharmacology and Immunotoxicology, 27(4), 671-681. (Pubitemid 43224203)
174. Nam, S., Ko, E., Park, S. K., Ko, S., Jun, C. Y., Shin, M. K., Hong, M. C., & Bae, H. (2005). Bee venom modulates murine Th1/Th2 lineage development. International Immunopharmacology, 5(9), 1406-1414. (Pubitemid 40813297)
175. Leitinger, N. (2003). Oxidized phospholipids as modulators of inflammation in atherosclerosis. Current Opinion in Lipidology, 14, 421-430.
176. Banchereau, J., & Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature, 392, 245-252. (Pubitemid 28155090)
177. Matzinger, P. (2002). The danger model: a renewed sense of self. Science, 296, 301-305.
178. Hartman Hartman, D. A., Tomchek, L. A., Lugay, J. R., Lewin, A. C., Chau, T. T., & Carlson, R. P. (1991). Comparison of antiinflammatory and antiallergic drugs in the melittin- and D49 PLA2-induced mouse paw edema models. Agents and Actions, 34(1-2), 84-88.
179. Lariviere, W. R., & Melzack, R. (1996). The bee venom test: a new tonic-pain test. Pain, 66(2-3), 271-277. (Pubitemid 26283997)
180. Schneider, H., & Urbanek, R. (1984). Humoral and cellular immune response of the rat to immunization with bee venom. Clinical and Experimental Immunology, 57, 449-453. (Pubitemid 14089395)
181. Magnan, A., Marin, V., Mely, L., Birnbaum, J., Romanet, S., Bongrand, P., & Vervloet, D. (2001). Venom immunotherapy induces monocyte activation. Clinical and Experimental Allergy, 31(8), 1303-1309. (Pubitemid 34208971)
182. Ribardo, D. A., Kuhl, K. R., Peterson, J. W., & Chopra, A. K. (2002). Role of melitin- like region within phospholipase A2- activating protein in biological function. Toxicon, 40, 519-526. (Pubitemid 34124051)
183. Rekka, E., Kourounakis, L., & Kourounakis, P. (1990). Antioxidant activity of interleukin production affected by honeybee venom. Arzneimittel-Forschung, 40, 912-913. (Pubitemid 20241090)